AB-Biotics SA (ABB):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AB-Biotics SA (ABB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8208
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AB-Biotics SA (AB-Biotics) is a provider of probiotics, pipeline products, specialty dietary supplements, and other functional ingredients. The company’s products comprise iron-containing ingredients, lactobacillus plantarum, probiotic products, gastrointestinal treatment products, proprietary supplements, lysozyme and defensin peptides, and infantile colic products. It also provides pyloriosis, radiobal products, vitamin K products, lactobacillus brevis, natural solutions, neuropharmagen testing products, and probiosis products, among others. AB-Biotics offers services such as protocol development, drug development, clinical testing services, financing, research and development, microbiology services, and project execution services, among others. The company markets and supplies its products in Spain and abroad. AB-Biotics is headquartered in Barcelona, Spain.

AB-Biotics SA (ABB) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AB-Biotics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AB-Biotics SA, Medical Devices Deals, 2012 to YTD 2018 9
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AB-Biotics SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
AB-Biotics Enters into Distribution Agreement with Mylan 11
Ab-Biotics Enters into Distribution Agreement with Laboratorios Bago for Neurofarmagen 12
AB-Biotics Enters into Co-Development Agreement with Beijing E-Biotics 13
AB-Biotics Enters Into Co-Promotion Agreement With Scienta Farma For Neurofarmagen 14
AB-Biotics Enters Into Co-Promotion Agreement With GlaxoSmithKline For Neurofarmagen 15
Licensing Agreements 16
Kaneka Americas Enters into Licensing Agreement with AB-Biotics 16
Ab-Biotics Enters into Option for Licensing Agreement with Wakamoto Pharma 17
AB-Biotics Enters into Licensing Agreement with Cilag 18
Equity Offering 19
AB-Biotics Raises USD5.4 Million in Public Offering of Shares 19
Asset Transactions 20
Frutarom Industries Acquires AB-Fortis Product from AB-Biotics 20
Acquisition 21
Ab-Biotics Acquires 10% Stakes in Access DX Laboratory 21
Almirall Acquires Stake In AB-Biotics, Biotechnology Company, For US$1.3 Million 22
AB-Biotics SA – Key Competitors 23
AB-Biotics SA – Key Employees 24
AB-Biotics SA – Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
AB-Biotics SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AB-Biotics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AB-Biotics SA, Deals By Therapy Area, 2012 to YTD 2018 8
AB-Biotics SA, Medical Devices Deals, 2012 to YTD 2018 9
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AB-Biotics Enters into Distribution Agreement with Mylan 11
Ab-Biotics Enters into Distribution Agreement with Laboratorios Bago for Neurofarmagen 12
AB-Biotics Enters into Co-Development Agreement with Beijing E-Biotics 13
AB-Biotics Enters Into Co-Promotion Agreement With Scienta Farma For Neurofarmagen 14
AB-Biotics Enters Into Co-Promotion Agreement With GlaxoSmithKline For Neurofarmagen 15
Kaneka Americas Enters into Licensing Agreement with AB-Biotics 16
Ab-Biotics Enters into Option for Licensing Agreement with Wakamoto Pharma 17
AB-Biotics Enters into Licensing Agreement with Cilag 18
AB-Biotics Raises USD5.4 Million in Public Offering of Shares 19
Frutarom Industries Acquires AB-Fortis Product from AB-Biotics 20
Ab-Biotics Acquires 10% Stakes in Access DX Laboratory 21
Almirall Acquires Stake In AB-Biotics, Biotechnology Company, For US$1.3 Million 22
AB-Biotics SA, Key Competitors 23
AB-Biotics SA, Key Employees 24

List of Figures
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AB-Biotics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AB-Biotics SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[AB-Biotics SA (ABB):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Veracyte Inc (VCYT):医療機器:M&Aディール及び事業提携情報
    Summary Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also …
  • Canam Group Inc:企業の戦略的SWOT分析
    Canam Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Hunting PLC (HTG)-石油・ガス分野:企業M&A・提携分析
    Summary Hunting PLC (Hunting) is a provider of energy services that manufactures and distributes products for the extraction of oil and gas. The company provides products for the construction, completion, and re-completion of wellbore development, and intervention and subsea support of wellbore prod …
  • Neuronetics Inc (STIM):医療機器:M&Aディール及び事業提携情報
    Summary Neuronetics Inc (Neuronetics) is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders. The company provides neurostar TMS therapy system used to treat patients with depressive disorder. Its neurostar TMS components comprise practice data ma …
  • JD Sports Fashion Plc:企業の戦略・SWOT・財務情報
    JD Sports Fashion Plc - Strategy, SWOT and Corporate Finance Report Summary JD Sports Fashion Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Mitsui O.S.K. Lines Ltd (9104)-石油・ガス分野:企業M&A・提携分析
    Summary Mitsui O.S.K. Lines Ltd (MOL) is a global marine logistic company. It owns and operates dry bulkers, tankers, LNG carriers, containerships, ferries & coastal RoRo ships, cruise ships. The company’s dry bulkers transport dry bulk cargo such as iron ore, coal, grains, wood, wood chips, cement, …
  • IBEX Technologies Inc (IBT):企業の財務・戦略的SWOT分析
    Summary IBEX Technologies Inc (IBEX) is a manufacturer and marketer of high-purity proprietary enzymes and recombinant from flavobacterium heparinum. The company provides enzymes such as heparinase I, heparinase II, heparinase III, chondroitinase AC and chondroitinase B. Its assays allow for the stu …
  • Fidia farmaceutici SpA-製薬・医療分野:企業M&A・提携分析
    Summary Fidia farmaceutici SpA (Fidia), a subsidiary of P&R S.p.A., is a healthcare products provider that specializes in research, development and manufacturing of hyaluronic acid-based products. The company develops and commercializes products for specific therapeutic areas which includes joint he …
  • Banyan Biomarkers Inc:医療機器:M&Aディール及び事業提携情報
    Summary Banyan Biomarkers Inc (Banyan Biomarkers) is a medical technology company that commercializes vitro diagnostic tests for the detection of traumatic brain injury and neurological diseases. The company’s product pipeline includes biomarkers for depression, hypoxic ischemic encephalopathy, neur …
  • Cardiovascular Systems Inc (CSII):製品パイプライン分析
    Summary Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for treating peripheral and coronary vascular disease. The company offers products such as peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accessorie …
  • IDFC Ltd (IDFC):企業の財務・戦略的SWOT分析
    IDFC Ltd (IDFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Corcept Therapeutics Inc (CORT):製薬・医療:M&Aディール及び事業提携情報
    Summary Corcept Therapeutics Inc (Corcept) is a research focused pharmaceutical company which discovers, develops and commercializes innovative therapeutics in the areas of psychiatric and metabolic diseases. The company focuses on developing drugs for the treatment of severe metabolic, oncologic an …
  • Umecrine Cognition AB-製薬・医療分野:企業M&A・提携分析
    Summary Umecrine Cognition AB (Umecrine), a subsidiary of Umecrine AB is a developer of treatments for neurological disorders in the central nervous system. The company develops pharmaceuticals for the treatment of acute life-threatening hepatic encephalopathy (HE) and long-term maintenance in minim …
  • Punjab & Sind Bank:企業の戦略・SWOT・財務情報
    Punjab & Sind Bank - Strategy, SWOT and Corporate Finance Report Summary Punjab & Sind Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Biosense Webster Inc:企業の製品パイプライン分析2018
    Summary Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures and markets cardiac arrhythmias products. The company’s products include ablation catheters, diagnostic catheters and access, ultrasound catheters and 3D cardiac …
  • Hovnanian Enterprises Inc:企業の戦略・SWOT・財務分析
    Hovnanian Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Hovnanian Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • HCL Technologies Ltd (HCLTECH):企業の財務・戦略的SWOT分析
    HCL Technologies Ltd (HCLTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Senju Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Senju Pharmaceutical Co Ltd (Senju) researches, develops, manufactures and markets pharmaceutical products for eye, ear, nose, throat, and skin. The company offers a wide range of ophthalmological products. Its product portfolio includes prescription products, OTC medicines and veterinary dr …
  • Diploma PLC (DPLM):企業の財務・戦略的SWOT分析
    Summary Diploma PLC (Diploma) is a supplier of technical products and services. The company operates through its business such as life sciences, seals and controls. Its life sciences segment supplies instrumentation, consumables, and related services to the healthcare and environmental industries. D …
  • Equinix Inc (EQIX):企業の財務・戦略的SWOT分析
    Equinix Inc (EQIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆